Health
India’s drugs regulator rejects Bharat Biotech’s request for COVID-19 vaccine trials on children – Xinhua | English.news.cn – Xinhua
NEW DELHI, Feb. 25 (Xinhua) — India’s drugs controller has rejected vaccine maker Bharat Biotech’s request to conduct clinical trials of Covaxin on children and asked the company to submit its report on the efficacy of the COVID-19 vaccine, local media said Thursday.
The drugs regulator’s rejection came after hearing an application by Hyderabad-based pharma company on Wednesday sought approval for Phase 3 clinical trials of Covaxin on children between 5-18 years of age.
The subject expert committee…
Continue Reading
